TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

62 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Asthma

    📍 Research Site · Mobile, AL · +27 more US sites · Get directions →

    A study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations and uncontrolled asthma receiving high-dose inhaled corticosteroid (ICS) plus at least one additional controller medication.

    ✓ Study care freePhase 3Ages 6–18Learn more →
  • Asthma

    A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

    Testing whether tezepelumab works and is safe for children with severe asthma

    📍 Research Site · Montgomery, AL · +29 more US sites · Get directions →

    To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

    ✓ Study care freePhase 3Ages 5–11Learn more →
  • Dementia / Alzheimer's

    Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

    Testing the safety and effects of two drugs for agitation in Alzheimer’s dementia

    📍 Esperanza Clinical · Murrieta, CA · +8 more US sites · Get directions →

    The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

    ✓ Study care freePhase 2Ages 55–90Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    PET Imaging Evaluation of [11C]SY08

    Testing a PET scan tracer to detect alpha-synuclein protein clumps in dementia and Parkinson’s

    📍 MGH · Charlestown, MA · Get directions →

    The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose of this study is to evaluate the use of \[11C\]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DLB and healthy controls.

    ✓ Study care freeEarly Phase 1Ages 50–80Learn more →
  • Asthma

    A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

    Testing an add-on treatment given every 6 months for severe asthma not controlled by inhaled

    📍 Research Site 13 · Bakersfield, CA · +12 more US sites · Get directions →

    The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks.

    ✓ Study care freePhase 3Ages 12–80Learn more →
  • COPD (chronic lung disease)Asthma

    The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

    Testing whether positive airway pressure helps a lung medicine (NAC) reach mucus plugs in asthma or

    📍 UCSF Airway Clinical Research Center · San Francisco, CA · Get directions →

    The goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions it aims to answer are: * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on mucus plug burden in the lungs than delivery of NAC without positive pressure.

    ✓ Study care freePhase 4Ages 18–85Learn more →
  • Asthma

    📍 Research Site · Chandler, AZ · +33 more US sites · Get directions →

    This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatment step of escalation of inhaled therapy to high-dose ICS-LABA.

    ✓ Study care freePhase 3Ages 12–75Learn more →
  • Asthma

    Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

    Testing a medicine in people with asthma to study lung changes

    📍 GSK Investigational Site · Brooksville, FL · +8 more US sites · Get directions →

    Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    Testing whether KarXT plus KarX-EC is safe and works for memory problems in Alzheimer’s disease

    📍 Healthy Brain Clinic · Long Beach, CA · +27 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    ✓ Study care freePhase 3Ages 60–85Learn more →
  • Asthma

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

    Studying what causes breathing out to get harder during asthma flare-ups

    📍 Arthur F Gelb Medical Corporation · Lakewood, CA · Get directions →

    The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent expiratory airflow obstruction. Treatment will include inhaled corticosteroids and long acting beta2agonists.

    ✓ Study care freePhase 4Ages 10–80Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

    Testing long-term safety and effectiveness of two medicines for agitation in Alzheimer’s dementia

    📍 Local Institution - 2609 · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

    Testing early IV magnesium sulfate for people with a moderate asthma flare

    📍 Oklahoma Children's Hospital · Oklahoma City, OK · Get directions →

    This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

    ✓ Study care freeEarly Phase 1Ages 5–17Learn more →
  • Dementia / Alzheimer's

    Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

    Studying whether ovarian hormones are linked to aging and Alzheimer’s risk in women

    📍 Mayo Clinic · Jacksonville, FL · +1 more US site · Get directions →

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

    ✓ Study care freePhase 4Ages 60+WomenLearn more →
  • Dementia / Alzheimer's

    A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    Testing whether yearly donanemab helps people with dementia after a prior study

    📍 Banner Alzheimer's Institute · Phoenix, AZ · +39 more US sites · Get directions →

    The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

    ✓ Study care freePhase 3Ages 55+Learn more →
  • Asthma

    A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

    Testing a medicine added to usual care to prevent asthma flare-ups in teens and adults with type 2

    📍 GSK Investigational Site · Newport Beach, CA · +7 more US sites · Get directions →

    The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

    ✓ Study care freePhase 3Ages 12+Learn more →
  • Asthma

    45th Multicenter Airway Research Collaboration

    Testing an emergency department treatment to prevent asthma attacks from coming back

    📍 MetroHealth · Cleveland, OH · Get directions →

    The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

    ✓ Study care freePhase 4Ages 18–54Learn more →
  • Asthma

    Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

    Testing a skin injection of dupilumab for asthma in children ages 2 to under 6

    📍 Phoenix Children's Hospital- Site Number : 8400001 · Phoenix, AZ · +13 more US sites · Get directions →

    This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted in 2 parts.

    ✓ Study care freePhase 3Ages 2–5Learn more →
  • Asthma

    Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

    Testing a new way to match asthma patients to biologic treatments using genetic and lab measures

    📍 Mayo Clinic · Scottsdale, AZ · +2 more US sites · Get directions →

    In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples.

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • Dementia / Alzheimer's

    A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

    Testing a drug called trontinemab for early Alzheimer’s disease dementia

    📍 Banner Alzheimer?s Institute · Phoenix, AZ · +32 more US sites · Get directions →

    The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

    Testing a treatment called KarXT plus KarX-EC for psychosis in people with Alzheimer's disease

    📍 Gilbert Neurology Partners/CCT Research · Gilbert, AZ · +5 more US sites · Get directions →

    The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Azithromycin for Critical Asthma - Pediatrics

    Testing azithromycin in children with severe asthma to change the immune response

    📍 Johns Hopkins All Children's Hospital · St. Petersburg, FL · Get directions →

    The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

    ✓ Study care freePhase 2Ages 3–17Learn more →
  • DepressionDementia / Alzheimer's

    Aβ Dynamics in LLMD

    Testing how treating depression may change brain markers linked to Alzheimer’s

    📍 NYU Langone Health · New York, NY · +1 more US site · Get directions →

    This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depression and the biological factors associated with AD is unknown, the only way to understand cause and associated risk is to treat the depressive symptoms and examine the effects on AD biomarkers.

    ✓ Study care freePhase 4Ages 60+Learn more →
  • Asthma

    CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

    Helping community health clinic clinicians prescribe recommended asthma care

    📍 Affinia healthcare, 2220 Lemp Ave · St Louis, MO · +6 more US sites · Get directions →

    Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers.

    ✓ Study care freePhase 4Ages 12+Learn more →
  • Dementia / Alzheimer's

    Epidemiology and Biomarker Study in Alzheimer's Disease

    Studying how memory changes over time and blood test results in people with dementia

    📍 Care Access - Houston · Houston, TX · Get directions →

    Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.

    ✓ Study care freePhase 3Ages 55–75Learn more →
  • Dementia / Alzheimer's

    📍 Endeavor Health Systems · Evanston, IL · Get directions →

    CMK-0301 is a multi-site, randomized clinical trial to evaluate the safety and efficacy of \[F-18\]Flornaptitril-PET (F-18 FNT-PET) for the prediction of clinical progression of Mild Cognitive Impairment (MCI) with either Suspected Chronic Traumatic Encephalopathy (CTE) or Alzheimer's Disease (AD). The primary objectives of the study are to: (1) To determine the accuracy of F-18 FNT-PET in prediction of clinical decline and (2) To assess the safety and tolerability of F-18 FNT.

    ✓ Study care freePhase 3Ages 45+Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    Testing a treatment (KarXT plus KarX-EC) for memory problems in Alzheimer’s dementia

    📍 Fullerton Neurology and Headache Center · Fullerton, CA · +29 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    ✓ Study care freePhase 3Ages 60–85Learn more →
  • Asthma

    A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

    Testing an added medicine given every 6 months for severe asthma not controlled

    📍 Research Site 23 · Northridge, CA · +33 more US sites · Get directions →

    The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks.

    ✓ Study care freePhase 3Ages 12–80Learn more →
  • Dementia / Alzheimer's

    PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

    Comparing tau brain scan images in different types of dementia

    📍 Perelman Center for Advance Medicine · Philadelphia, PA · Get directions →

    The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Dementia / Alzheimer's

    A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

    Testing a drug combination to treat agitation in adults with Alzheimer’s

    📍 Chandler Clinical Trials, LLC · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Ventilation and Perfusion in Asthmatics

    Testing how inhaled asthma medicines change breathing and blood flow in adults

    📍 University of Miami - Converge Miami · Miami, FL · Get directions →

    Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • Asthma

    Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

    Comparing two as-needed inhalers to prevent severe asthma flare-ups in teens

    📍 Research Site · Anchorage, AK · +39 more US sites · Get directions →

    The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of asthma and at least one severe exacerbation in the prior year.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Dementia / Alzheimer's

    Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

    Testing an education and support group for people with progressive aphasia and their caregivers

    📍 University of Texas at Austin · Austin, TX · Get directions →

    The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • Dementia / Alzheimer's

    Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

    Testing whether rTMS affects memory and brain function in dementia

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    In this research study we want to learn more about the effects of non-invasive brain stimulation on memory and brain-network function in cognitively unimpaired older adults and in patients with amnestic mild cognitive impairment (aMCI). This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS).

    ✓ Study care freeEarly Phase 1Ages 40–99Learn more →
  • Dementia / Alzheimer's

    A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    Testing the safety and side effects of Zunveyl in people with mild to moderate Alzheimer’s

    📍 Tekton Research Saint Louis Psychiatry · St Louis, MO · Get directions →

    The primary purpose of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's disease.

    ✓ Study care freePhase 4Ages 50+Learn more →
  • Dementia / Alzheimer's

    A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

    Testing trontinemab for safety and effectiveness in early Alzheimer’s disease dementia

    📍 University of Alabama at Birmingham · Birmingham, AL · +34 more US sites · Get directions →

    The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer's

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    Screening people who may be eligible for Alzheimer’s disease studies for dementia

    📍 University of Alabama at Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer's

    Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

    Testing a sleep medicine for insomnia symptoms in a person with dementia

    📍 Nova Scotia Health · Halifax, Nova Scotia · Get directions →

    Insomnia is a highly common, chronic disorder that is distressful for the patient but also for caregivers and can give rise to a heavy burden on the healthcare team. Sleeping aids like benzodiazepines and other sedatives (e.g., zolpidem, zopiclone) have been widely used to help treat insomnia.

    ✓ Study care freePhase 4Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    Testing a medicine for psychosis in adults with moderate to severe Alzheimer’s

    📍 Local Institution - 1227 · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Magnesium Trial in Acute Asthma in Emergency Department

    Testing intravenous magnesium for children with severe asthma after ER treatment

    📍 Alberta Children's Hospital · Calgary, Alberta · Get directions →

    Despite optimal initial emergency department (ED) therapy, 50% of children with severe acute asthma have ongoing moderate-severe respiratory distress. Guidelines recommend intravenous magnesium (IVMg) for them, yet evidence for IVMg efficacy is scant and disparate.

    ✓ Study care freePhase 3Ages 2–17Learn more →
  • Dementia / Alzheimer's

    Biomarker Exploration in Aging, Cognition and Neurodegeneration

    Testing how MRI, PET scans, and memory tests can detect early dementia

    📍 University of California, Irvine · Irvine, CA · Get directions →

    The purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline.

    ✓ Study care freePhase 3Ages 60+Learn more →
  • Dementia / Alzheimer's

    A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    Testing a potential Alzheimer disease treatment in people with early AD genetic risk

    📍 University of Alabama in Birmingham · Birmingham, AL · +10 more US sites · Get directions →

    The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on biomarkers (measures of the disease including brain scans, blood and spinal fluid tests), examine safety data to identify any potential benefits or risks, and examine how well participants can tolerate remternetug.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    📍 Teva Investigational Site 12087 · Phoenix, AZ · +39 more US sites · Get directions →

    The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The planned study duration for each participant is approximately 10 weeks, excluding an optional prescreening visit.

    ✓ Study care freePhase 3Ages 12+Learn more →
  • Dementia / Alzheimer's

    Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

    Testing a medicine called masupirdine versus placebo for agitation in Alzheimer’s dementia

    📍 Advanced Research Center, Inc. · Anaheim, CA · +26 more US sites · Get directions →

    This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

    Studying how nerve cell loss affects thinking ups and downs in Lewy body dementia

    📍 Virginia Commonwealth University · Richmond, VA · Get directions →

    The proposed study aims to address the critical gaps in understanding the mechanisms of CF (Cognitive Fluctuations) by leveraging recently emerged molecular biomarkers, advanced neuroimaging techniques to assess measures of cholinergic degeneration, and synchronous EEG and assessments of attention. One of the overarching innovations of study is combining all of these assessments into one integrated research plan

    ✓ Study care freePhase 4Ages 50–89Learn more →
  • Asthma

    A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

    Testing whether an asthma medicine can help people achieve full asthma control

    💵 May compensate

    📍 Sir Charles Gairdner Hospital · Nedlands, Western Australia · Get directions →

    This study tests whether an asthma medication called dupilumab can help people achieve complete asthma control (called "remission") when given earlier in their disease, before asthma becomes severe. Currently, most people with asthma only receive advanced treatments like biologics after their condition has worsened significantly and caused lung damage.

    ✓ Study care freePhase 3Ages 18–79Learn more →
  • Dementia / Alzheimer's

    Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

    Studying nighttime agitation and restless legs in people with Alzheimer’s

    📍 The University of Texas at Austin · Austin, TX · Get directions →

    Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation.

    ✓ Study care freePhase 4Ages 55+Learn more →
  • Asthma

    Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol

    Testing how breathing tests and mannitol affect cough-related airway reactions in people with asthma

    📍 Kingston Health Sciences Centre · Kingston, Ontario · Get directions →

    The objectives of this study are to determine the sensory-mechanical responses to Eucapneic Voluntary Hyperventilation (EVH) and Mannitol in individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH) and compare these responses to a control group of healthy individuals without asthma or chronic cough. We hypothesize: 1.

    ✓ Study care freePhase 4Ages 18–65Learn more →
  • Dementia / Alzheimer's

    Preventing Alzheimer's With Cognitive Training

    Testing whether cognitive training can help prevent Alzheimer’s disease

    📍 University of Florida · Gainesville, FL · +6 more US sites · Get directions →

    Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia.

    ✓ Study care freePhase 3Ages 65+Learn more →
  • DepressionDementia / Alzheimer's

    Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

    Testing psilocybin to treat depression in people with early Alzheimer’s or mild cognitive decline

    📍 Johns Hopkins Center for Psychedelic and Consciousness Research · Baltimore, MD · Get directions →

    This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve quality of life in those individuals.

    ✓ Study care freeEarly Phase 1Ages 18–85Learn more →
  • Heart / cardiovascular diseaseDementia / Alzheimer's

    Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    Testing whether lowering cholesterol in older adults affects heart and memory outcomes

    📍 University of Alabama at Birmingham · Birmingham, AL · +37 more US sites · Get directions →

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo.

    ✓ Study care freePhase 4Ages 75+Learn more →
  • Dementia / Alzheimer's

    [18F]PI-2620 Phase 3 Histopathological Study

    Testing a PET brain scan to detect tau buildup in Alzheimer’s

    📍 Barrow Neurological Institute · Phoenix, AZ · +22 more US sites · Get directions →

    This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Asthma

    Viral Infection in Asthma (VIA) Study

    Testing whether dupilumab can prevent asthma symptom worsening after a cold virus exposure

    📍 University of Virginia · Charlottesville, VA · Get directions →

    Often when people with asthma get a virus caused by the common cold (rhinovirus), they also experience an increase or worsening of their asthma symptoms. The purpose of this study is to see if the study medication dupilumab helps prevent those with mild to moderate asthma from having increased asthma symptoms, after being exposed to an experimental rhinovirus inoculation.

    ✓ Study care freePhase 4Ages 18–40Learn more →
  • Dementia / Alzheimer's

    Nabilone for Agitation Blinded Intervention Trial

    Testing nabilone as a treatment for agitation in people with Alzheimer’s dementia

    📍 University of Calgary · Calgary, Alberta · Get directions →

    This study will look at whether nabilone is an effective treatment for agitation in Alzheimer's disease (AD) patients. Agitation is highly prevalent in patients with AD and is one of the most distressing and challenging-to-treat symptoms.

    ✓ Study care freePhase 3Ages 55+Learn more →
  • Dementia / Alzheimer's

    Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

    Testing glutathione on brain fuel use and inflammation in dementia

    📍 Baylor College of Medicine · Houston, TX · Get directions →

    Alzheimer's disease (AD) is associated with significant, progressive cognitive decline. Key defects in mitochondrial fuel metabolism insulin resistance, inflammation and decreased brain glucose uptake are linked to AD.

    ✓ Study care freeEarly Phase 1Ages 55–85Learn more →
  • Asthma

    Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

    Testing how dupilumab or placebo changes mucus-clearing in people with moderate to severe asthma

    📍 The University of Pittsburgh Asthma Institute at UPMC · Pittsburgh, PA · Get directions →

    Single center, randomized, placebo- controlled study to assess change in mucociliary clearance of moderate to severe asthma patients after treatment with dupilumab or placebo.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Dementia / Alzheimer's

    A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    Testing drugs to see how they affect brain changes in people with a genetic form of early

    📍 University of Alabama in Birmingham · Birmingham, AL · +10 more US sites · Get directions →

    The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Stage 1 will determine if treatment with the study drug prevents or slows the rate of amyloid beta (Aβ) pathological disease accumulation demonstrated by Aβ positron emission tomography (PET) imaging.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    📍 Novartis Investigative Site · CABA, Buenos Aires · Get directions →

    The purpose of this study is to evaluate the superiority in terms of efficacy and evaluate the safety of QMF149 (indacaterol (acetate) / mometasone (furoate)) compared to budesonide in children from 6 to less than 12 years of age with asthma. * The study duration will be up to 37 weeks including an investigational treatment duration of 12 weeks and a comparator treatment duration of 12 weeks.

    ✓ Study care freePhase 3Ages 6–11Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Comparing Antipsychotic Medications in LBD Over Time

    Comparing medicines to see which works better for hallucinations or delusions in Lewy body disease

    📍 University Health System · San Antonio, TX · +1 more US site · Get directions →

    The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).

    ✓ Study care freePhase 4Learn more →
  • Asthma

    A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

    Comparing two asthma inhaler treatments in teens to measure lung function

    📍 GSK Investigational Site · Birmingham, AL · +27 more US sites · Get directions →

    The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Asthma

    Therapeutic Relevance of Abnormal Airway Morphology in Asthma

    Studying how abnormal airway shape in asthma relates to symptoms and attacks

    📍 St. Joseph's Healthcare Hamilton · Hamilton, Ontario · Get directions →

    Most individuals with asthma can effectively manage their symptoms and maintain normal lung function using inhaled medications, unfortunately, there is a subset of asthma sufferers whose symptoms, lung function, and risk of asthma attacks remain unimproved despite conventional inhaled medications. There could be several reasons for this.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Showing the first 60 of 62. Add filters or a location to narrow down.